Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Familial Dilated Cardiomyopathy

Dilated cardiomyopathy is a disease of the muscle of the heart which results in an enlarged heart with thin walls and a large pumping chamber. Dilated cardiomyopathy has many potential causes, including heart attacks, heart valve disease, high blood pressure, infections, and drugs toxic to the heart.

Condition Spotlight

Stanford Hospital & Clinics: Dilated Cardiomyopathy Explained Watch Video

Clinical Trials for Familial Dilated Cardiomyopathy

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Familial Dilated Cardiomyopathy, Heart Failure , Hypertrophic Cardiomyopathy

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy Cardiomyopathy, Familial Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Familial Dilated Cardiomyopathy